Related Experiment Videos
[Atrial fibrillation]
1Service de cardiologie, CHU Hôpital Nord, 13915 Marseille Cedex 20. slevy@ap-hm.fr
La Revue Du Praticien
|May 12, 2004
Summary
Atrial fibrillation (AF) management focuses on preventing stroke and controlling symptoms. Treatment options range from anticoagulation and antiarrhythmic drugs to non-pharmacological interventions like ablation for refractory cases.
Area of Science:
- Cardiology
- Electrophysiology
- Internal Medicine
Context:
- Atrial fibrillation (AF) is a prevalent arrhythmia with significant morbidity and mortality.
- AF complications include disabling symptoms, hemodynamic compromise, and embolic events, primarily cerebrovascular accidents.
- Most AF patients (70%) have underlying heart disease, influencing therapeutic strategies.
Purpose:
- To outline therapeutic endpoints for atrial fibrillation management.
- To detail emergency and long-term treatment strategies for AF.
- To guide the selection of antiarrhythmic and non-pharmacological therapies based on patient-specific factors.
Summary:
- Therapeutic goals in AF include preventing embolic events with anticoagulation and managing symptoms/hemodynamics via rhythm or rate control.
- Emergency AF treatment prioritizes electrical cardioversion for hemodynamic compromise, otherwise antiarrhythmic drugs or rate control are employed.
- Therapy selection for AF recurrence prevention considers AF type, symptoms, cardiac comorbidities, and left ventricular function, with non-pharmacological options for refractory patients.
Impact:
- Effective AF management reduces stroke risk and improves patient quality of life.
- Tailored treatment strategies optimize outcomes for diverse AF patient populations.
- Non-pharmacological interventions offer valuable alternatives for highly symptomatic patients unresponsive to drug therapy.